Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: Role for peripheral TNFα, IL-1β and IL-10

European Journal of Pharmacology

Volumn 749, Issue , 2015, Pages 62-72

  Carvalho, Thacyana T ^a   Borghi, Sergio M ^a   Pinho Ribeiro, Felipe A ^a   Mizokami, Sandra S ^a   Cunha, Thiago M ^b   Ferreira, Sergio H ^b   Cunha, Fernando Q ^b   Casagrande, Rubia ^a   Verri, Waldiceu A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokine; G CSF; Morphine; Pain; Pentoxifylline; Thalidomide

Indexed keywords

ETANERCEPT; GRANULOCYTE COLONY STIMULATING FACTOR; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MORPHINE; PENTOXIFYLLINE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; IL10 PROTEIN, MOUSE; IMMUNOGLOBULIN G; NARCOTIC ANALGESIC AGENT; TNFR-FC FUSION PROTEIN; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; HYPERALGESIA; LEUKOCYTE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PROTEIN DEFICIENCY; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; LEUKOCYTE COUNT; METABOLISM; SKIN;

ANALGESICS, OPIOID; ANIMALS; GRANULOCYTE COLONY-STIMULATING FACTOR; HYPERALGESIA; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; LEUKOCYTE COUNT; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; PENTOXIFYLLINE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SKIN; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921502659     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.12.023     Document Type: Article

References (78)

1. M. Akdis, S. Burgler, R. Crameri, T. Eiwegger, H. Fujita, E. Gomez, S. Klunker, N. Meyer, L. O'Mahony, O. Palomares, C. Rhyner, N. Ouaked, A. Schaffartzik, W. Van De Veen, S. Zeller, M. Zimmermann, and C.A. Akdis Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases J. Allergy Clin. Immunol. 127 2011 701 721 (e1-70)
2. K. Amirshahrokhi, and M. Ghazi-Khansari Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines Cytokine 60 2012 522 527
3. K. Amirshahrokhi Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice Int. Immunopharmacol. 17 2013 210 215
4. M. Battiwalla, and P.L. McCarthy Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice Bone Marrow Transplant. 43 2009 351 356
5. E. Bien, M. Krawczyk, E. Izycka-Swieszewska, P. Trzonkowski, B. Kazanowska, E. Adamkiewicz-Drozynska, and A. Balcerska Serum IL-10 and IL-12 levels reflect the response to chemotherapy but are influenced by G-CSF therapy and sepsis in children with soft tissue sarcomas Postepy Hig. Med. Dosw. 67 2013 517 528
6. A.M. Binshtok, H. Wang, K. Zimmermann, F. Amaya, D. Vardeh, L. Shi, G.J. Brenner, R.R. Ji, B.P. Bean, C.J. Woolf, and T.A. Samad Nociceptors are interleukin-1beta sensors J. Neurosci. 28 2008 14062 14073
7. S.M. Borghi, A.C. Zarpelon, F.A. Pinho-Ribeiro, R.D. Cardoso, M.C. Martins-Pinge, R.I. Tatakihara, T.M. Cunha, S.H. Ferreira, F.Q. Cunha, R. Casagrande, and W.A. Verri Jr. Role of TNF-α/TNFR1 in intense acute swimming-induced delayed onset muscle soreness in mice Physiol. Behav. 128 2014 277 287
8. S.M. Borghi, A.C. Zarpelon, F.A. Pinho-Ribeiro, R.D. Cardoso, T.M. Cunha, J.C. Alves-Filho, S.H. Ferreira, F.Q. Cunha, R. Casagrande, and W.A. Verri Jr. Targeting interleukin-1β reduces intense acute swimming-induced muscle mechanical hyperalgesia in mice J. Pharm. Pharmacol. 66 2014 1009 1020
9. E.M. Boneberg, and T. Hartung Granulocyte colony-stimulating factor attenuates LPS-stimulated IL-1beta release via suppressed processing of proIL-1beta, whereas TNF-alpha release is inhibited on the level of proTNF-alpha formation Eur. J. Immunol. 32 2002 1717 1725
10. I. Breitkreutz, and K.C. Anderson Thalidomide in multiple myeloma - clinical trials and aspects of drug metabolism and toxicity Expert Opin. Drug Metab. Toxicol. 4 2008 973 985
11. C.M. Bunce, P.J. French, J. Durham, R.A. Stockley, R.H. Michell, and G. Brown Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3 Leukemia 8 1994 595 604
12. I.L. Calil, A.C. Zarpelon, A.T. Guerrero, J.C. Alves-Filho, S.H. Ferreira, F.Q. Cunha, T.M. Cunha, and W.A. Verri Jr. Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw PLoS One 9 2014 e90013
13. T.T. Carvalho, T. Flauzino, E.S. Otaguiri, A.P. Batistela, A.C. Zarpelon, T.M. Cunha, S.H. Ferreira, F.Q. Cunha, and W.A. Verri Jr. Granulocyte-colony stimulating factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice Pharmacol. Biochem. Behav. 98 2011 188 195
14. J.P. Cata, H.R. Weng, and P.M. Dougherty The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats Brain Res. 1229 2008 100 110
15. N. Chauhan, R. Taliyan, and P.L. Sharma Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain Naunyn Schmiedebergs Arch. Pharmacol. 385 2012 527 538
16. F.Q. Cunha, S. Poole, B.B. Lorenzetti, and S.H. Ferreira The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia Br. J. Pharmacol. 107 1992 660 664
17. J.M. Cunha, F.Q. Cunha, S. Poole, and S.H. Ferreira Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist Br. J. Pharmacol. 130 2003 1418 1424
18. T.M. Cunha, W.A. Verri Jr., G.G. Vivancos, I.F. Moreira, S. Reis, C.A. Parada, F.Q. Cunha, and S.H. Ferreira An electronic pressure-meter nociception paw test for mice Braz. J. Med. Biol. Res. 37 2004 401 407
19. D.C. Dale, M.A. Bonilla, M.W. Davis, A.M. Nakanishi, W.P. Hammond, J. Kurtzberg, W. Wang, A. Jakubowski, E. Winton, P. Lalezari, W. Robinson, J.A. Glaspy, S. Emerson, J. Gabrilove, M. Vincent, and L.A. Boxer A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia Blood 81 1993 2496 2502
20. J. Devulder, A. Jacobs, U. Richarz, and H. Wiggett Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain Br. J. Anaesth. 103 2009 576 585
21. R.P. Donnelly, H. Dickensheets, and D.S. Finbloom The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes J. Interferon Cytokine Res. 19 1999 563 573
22. M. Dorazil-Dudzik, J. Mika, M.K. Schafer, Y. Li, I. Obara, J. Wordliczek, and B. Przewłocka The effects of local pentoxifylline and propentofylline treatment on formalin-induced pain and tumor necrosis factor-alpha messenger RNA levels in the inflamed tissue of the rat paw Anesth. Analg. 98 2004 1566 1573
23. N. Eijkelkamp, C.J. Heijnen, H.L. Willemen, R. Deumens, E.A. Joosten, W. Kleibeuker, I.J. den Hartog, C.T. van Velthoven, C. Nijboer, M.A. Nassar, G.W. Dorn 2nd, J.N. Wood, and A. Kavelaars GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain J. Neurosci. 30 2010 2138 2149
24. D.M. Essayan Cyclic nucleotide phosphodiesterases J. Allergy Clin. Immunol. 108 2001 671 680
25. S.H. Ferreira, B.B. Lorenzetti, A.F. Bristow, and S. Poole Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue Nature 334 1988 698 700
26. Filgrastim Package Insert Kirin-Amgen, Thousand Oaks, CA, 2010. 21, pp. 1-28.
27. K. Futosi, S. Fodor, and A. Mócsai Neutrophil cell surface receptors and their intracellular signal transduction pathways Int. Immunopharmacol. 17 2013 638 650
28. Y.J. Gao, and R.R. Ji Chemokines, neuronal-glial interactions, and central processing of neuropathic pain Pharmacol. Ther. 126 2010 56 68
29. A. Gaultier, S. Arandjelovic, X. Li, J. Janes, N. Dragojlovic, G.P. Zhou, J. Dolkas, R.R. Myers, S.L. Gonias, and W.M. Campana A shed form of LDL receptor-related protein-1 regulates peripheral nerve injury and neuropathic pain in rodents J. Clin. Investig. 118 2008 161 172
30. X. Gu, Y. Zheng, B. Ren, R. Zhang, F. Mei, J. Zhang, and Z. Ma Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model Mol. Pain 6 2010 64
31. M. Inoue, T. Arikawa, Y.H. Chen, Y. Moriwaki, M. Price, M. Brown, J.R. Perfect, and M.L. Shinohara T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation Proc. Natl. Acad. Sci. USA 111 2014 5295 5300
32. R.R. Ji, and G. Strichartz Cell signaling and the genesis of neuropathic pain Sci. STKE 252 2004 (re14)
33. H.M. Jiang, H.X. Wang, H. Yang, X.J. Zeng, C.S. Tang, J. Du, and H.H. Li Role for granulocyte colony stimulating factor in angiotensin II-induced neutrophil recruitment and cardiac fibrosis in mice Am. J. Hypertens. 26 2013 1224 1233
34. J.A. Keifer, D.C. Guttridge, B.P. Ashburner, and A.S. Baldwin Jr. Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity J. Biol. Chem. 276 2001 22382 22387
35. W.M. Kim, C.W. Jeong, S.H. Lee, Y.O. Kim, J.H. Cui, and M.H. Yoon The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone cancer-induced pain through synergistic interaction Anesth. Analg. 113 2011 934 940
36. M. Lambertini, L. Del Mastro, A. Bellodi, and P. Pronzato The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs) Crit. Rev. Oncol. Hematol. 89 2014 112 128
37. H.G. Lee, W.M. Kim, M.H. Yoon, A.R. Park, and J.I. Choi Synergistic anti-allodynic effect between intraperitoneal thalidomide and morphine on rat spinal nerve ligation-induced neuropathic pain Korean J. Anesthesiol. 65 2013 331 336
38. S. Liu, Y.P. Liu, W.B. Song, and X.J. Song EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord Pain 154 2013 2823 2835
39. C.H. Lu, P.C. Chao, C.O. Borel, C.P. Yang, C.C. Yeh, C.S. Wong, and C.T. Wu Preincisional intravenous pentoxifylline attenuating perioperative cytokine response, reducing morphine consumption, and improving recovery of bowel function in patients undergoing colorectal cancer surgery Anesth. Analg. 99 2004 1465 1471
40. S. Majumder, S.R. Sreedhara, S. Banerjee, and S. Chatterjee TNF-α signaling beholds thalidomide saga: a review of mechanistic role of TNF-α signaling under thalidomide Curr. Top. Med. Chem. 12 2012 1456 1467
41. J. Marcinkiewicz, A. Grabowska, R. Lauterbach, and M. Bobek Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages Immunopharmacology 49 2000 335 343
42. C. Meierhofer, S. Dunzendorfer, and C.J. Wiedermann Protein kinase C-dependent effects on leukocyte migration of thalidomide J. Infect. Dis. 180 1999 216 219
43. M.L. Melo, G.A. Brito, R.C. Soares, S.B. Carvalho, J.V. Silva, P.M. Soares, M.L. Vale, M.H. Souza, F.Q. Cunha, and R.A. Ribeiro Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide Cancer Chemother. Pharmacol. 61 2008 775 784
44. J. Mika, M. Osikowicz, W. Makuch, and B. Przewlocka Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain Eur. J. Pharmacol. 560 2007 142 149
45. J. Mika, A. Wawrzczak-Bargiela, M. Osikowicz, W. Makuch, and B. Przewlocka Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice Brain Behav. Immun. 23 2009 75 84
46. E.D. Milligan, E.M. Sloane, S.J. Langer, P.E. Cruz, M. Chacur, L. Spataro, J. Wieseler-Frank, S.E. Hammack, S.F. Maier, T.R. Flotte, J.R. Forsayeth, L.A. Leinwand, R. Chavez, and L.R. Watkins Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10 Mol. Pain 1 2005 9
47. A.L. Moreira, E.P. Sampaio, A. Zmuidzinas, P. Frindt, K.A. Smith, and G. Kaplan Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation J. Exp. Med. 177 1993 1675 1680
48. M. Morell, L. Souza-Moreira, M. Caro, F. O'Valle, I. Forte-Lago, L. de Lecea, E. Gonzalez-Rey, and M. Delgado Analgesic effect of the neuropeptide cortistatin in murine models of arthritic inflammatory pain Arthritis Rheumatol. 65 2013 1390 1401
49. G. Murdaca, F. Spanò, M. Contatore, A. Guastalla, O. Magnani, and F. Puppo Efficacy and safety of etanercept in chronic immune-mediated disease Expert Opin. Drug Saf. 13 2014 649 661
50. Y.Y. Ng, Y.M. Chen, T.J. Tsai, X.R. Lan, W.C. Yang, and H.Y. Lan Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats Am. J. Nephrol. 29 2009 43 53
51. X. Niu, D. He, S. Deng, W. Li, Y. Xi, C. Xie, T. Jiang, J.Z. Zhang, C. Dong, and G. Chen Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis Mol. Immunol. 49 2011 290 296
52. K. Obata, H. Yamanaka, Y. Dai, T. Mizushima, T. Fukuoka, A. Tokunaga, and K. Noguchi Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats Eur. J. Neurosci. 20 2004 2881 2895
53. S. Pezet, F. Marchand, R. D'Mello, J. Grist, A.K. Clark, M. Malcangio, A.H. Dickenson, R.J. Williams, and S.B. McMahon Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions J. Neurosci. 28 2008 4261 4270
54. K.W. Poh, J.F. Yeo, and W.Y. Ong MicroRNA changes in the mouse prefrontal cortex after inflammatory pain Eur. J. Pain 15 2011 801 812
55. S. Poole, F.Q. Cunha, S. Selkirk, B.B. Lorenzetti, and S.H. Ferreira Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10 Br. J. Pharmacol. 115 1995 684 688
56. M.S. Putinatti, J.C. Lastória, and C.R. Padovani Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day An. Bras. Dermatol. 89 2014 266 272
57. R.A. Ribeiro, M.L. Vale, S.H. Ferreira, and F.Q. Cunha Analgesic effect of thalidomide on inflammatory pain Eur. J. Pharmacol. 391 2000 97 103
58. A. Ribeiro de Jesus, T. Luna, R. Pacheco de Almeida, P.R. Machado, and E.M. Carvalho Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections Int. Immunopharmacol. 8 2008 1344 1353
59. C. Santjohanser, C. Knieper, C. Franz, K. Hirv, O. Meri, M. Schleyer, W. Würfel, and B. Toth Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage Arch. Immunol. Ther. Exp. 61 2013 159 164
60. M. Schäfers, J. Brinkhoff, S. Neukirchen, M. Marziniak, and C. Sommer Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice Neurosci. Lett. 310 2001 113 116
61. M. Schäfers, L.S. Sorkin, and C. Sommer Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats Pain 104 2003 579 588
62. H. Schmidt, K. Stuertz, W. Brück, V. Chen, A.K. Stringaris, F.R. Fischer, and R. Nau Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis Scand. J. Immunol. 49 1999 481 486
63. M. Schweizerhof, S. Stosser, M. Kurejova, C. Njoo, V. Gangadharan, N. Agarwal, M. Schmelz, K.K. Bali, C.W. Michalski, S. Brugger, A. Dickenson, D.A. Simone, and R. Kuner Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain Nat. Med. 15 2009 802 807
64. B. Settles, A. Stevenson, K. Wilson, C. Mack, T. Ezell, M.F. Davis, and L.D. Taylor Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide Cell. Mol. Biol. 47 2001 1105 1114
65. K. Shimizu, W. Guo, H. Wang, S. Zou, S.C. LaGraize, K. Iwata, F. Wei, R. Dubner, and K. Ren Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors Mol. Pain 5 2009 75
66. C.I. Svensson, M. Marsala, A. Westerlund, N.A. Calcutt, W.M. Campana, J.D. Freshwater, R. Catalano, Y. Feng, A.A. Protter, B. Scott, and T.L. Yaksh Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing J. Neurochem. 86 2003 1534 1544
67. N. Uçeyler, M. Schäfers, and C. Sommer Mode of action of cytokines on nociceptive neurons Exp. Brain Res. 196 2009 67 78
68. M.L. Vale, V.M. Benevides, D. Sachs, G.A. Brito, F.A. da Rocha, S. Poole, S.H. Ferreira, F.Q. Cunha, and R.A. Ribeiro Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain Br. J. Pharmacol. 143 2004 833 844
69. A.M. van Furth, E.M. Verhard-Seijmonsbergen, R. van Furth, and J.A. Langermans Effects of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1beta and IL-10 by human leukocytes Immunology 91 1997 193 196
70. W.A. Verri Jr., T.M. Cunha, C.A. Parada, S. Poole, F.Q. Cunha, and S.H. Ferreira Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol. Ther. 112 2006 116 138
71. W.A. Verri Jr., F.O. Souto, S.M. Vieira, S.C. Almeida, S.Y. Fukada, D. Xu, J.C. Alves-Filho, T.M. Cunha, A.T. Guerrero, R.B. Mattos-Guimaraes, F.R. Oliveira, M.M. Teixeira, J.S. Silva, I.B. McInnes, S.H. Ferreira, P. Louzada-Junior, F.Y. Liew, and F.Q. Cunha IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy Ann. Rheum. Dis. 69 2010 1697 1703
72. S. Vircheva, A. Alexandrova, A. Georgieva, P. Mateeva, R. Zamfirova, M. Kubera, and M. Kirkova In vivo effects of pentoxifylline on enzyme and non-enzyme antioxidant levels in rat liver after carrageenan-induced paw inflammation Cell Biochem. Funct. 28 2010 668 672
73. Z.H. Wang, X.Y. Zeng, S.P. Han, G.X. Fan, and J.Y. Wang Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury Neurochem. Res. 37 2012 1811 1819
74. T. Wei, I. Sabsovich, T.Z. Guo, X. Shi, R. Zhao, W. Li, C. Geis, C. Sommer, W.S. Kingery, and D.J. Clark Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome Eur. J. Pain 13 2009 253 262
75. H.L. Willemen, N. Eijkelkamp, H. Wang, R. Dantzer, G.W. Dorn 2nd, K.W. Kelley, C.J. Heijnen, and A. Kavelaars Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling Pain 150 2010 550 560
76. J. Wordliczek, A.M. Szczepanik, M. Banach, J. Turchan, M. Zembala, M. Siedlar, R. Przewlocki, W. Serednicki, and B. Przewlocka The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients Life Sci. 66 2000 1155 1164
77. J.T. Xu, H.Y. Tu, W.J. Xin, X.G. Liu, G.H. Zhang, and C.H. Zhai Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats Exp. Neurol. 206 2007 269 279
78. M. Zelenka, M. Schäfers, and C. Sommer Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain Pain 116 2005 257 263